Thomas J. Matthews spends much of his time researching Virology, Virus, Ecology, Insular biogeography and Immunology. Lymphocyte proliferation is closely connected to Vaccinia in his research, which is encompassed under the umbrella topic of Virology. His research integrates issues of Gp41, Enfuvirtide, Molecular biology, Antibody and Peptide in his study of Virus.
His study in the field of Biodiversity, Habitat destruction, Urban ecology and Urbanization is also linked to topics like Pollinator decline. Thomas J. Matthews combines subjects such as Evolutionary dynamics, Biological dispersal and Archipelago with his study of Biodiversity. His study in Insular biogeography is interdisciplinary in nature, drawing from both Community and Environmental resource management.
His primary areas of study are Ecology, Virology, Species richness, Insular biogeography and Virus. His Ecology research focuses on Archipelago, Relative abundance distribution, Beta diversity, Nestedness and Relative species abundance. His Virology study incorporates themes from Molecular biology and Antibody, Immunology, Immunogenicity.
His work on Macroecology as part of his general Species richness study is frequently connected to Inverse synthetic aperture radar, thereby bridging the divide between different branches of science. His Insular biogeography study integrates concerns from other disciplines, such as Evolutionary dynamics, Community, Species-area curve and Species discovery curve. His Virus study combines topics in areas such as Amino acid, Vaccinia, Gp41 and Peptide.
His scientific interests lie mostly in Ecology, Beta diversity, Species richness, Species-area curve and Insular biogeography. His is involved in several facets of Ecology study, as is seen by his studies on Nestedness, Archipelago, Relative species abundance, Biodiversity and Species diversity. His Archipelago research is multidisciplinary, incorporating perspectives in Subtropics, Ecology, Habitat fragmentation and Biogeography.
His Biodiversity research is multidisciplinary, incorporating elements of Ecosystem and Endemism. His work on Macroecology as part of general Species richness research is frequently linked to Forest plot, bridging the gap between disciplines. His Insular biogeography research includes elements of Community and Functional diversity.
Thomas J. Matthews mainly investigates Ecology, Species richness, Species-area curve, Beta diversity and Archipelago. Much of his study explores Ecology relationship to Biological dispersal. His work on Insular biogeography and Macroecology is typically connected to Global consistency as part of general Species richness study, connecting several disciplines of science.
He interconnects Habitat fragmentation and Subtropics in the investigation of issues within Species-area curve. His work is dedicated to discovering how Beta diversity, Environmental resource management are connected with Habitat destruction and Biodiversity and other disciplines. His biological study spans a wide range of topics, including Taxon, Range, Ecology and Biogeography.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection
Carl T. Wild;Diane C. Shugars;Teresa K. Greenwell;Charlene B. McDanal.
Proceedings of the National Academy of Sciences of the United States of America (1994)
Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides
Thomas J. Palker;Michael E. Clark;Alphonse J. Langlois;Thomas J. Matthews.
Proceedings of the National Academy of Sciences of the United States of America (1988)
Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides
Laurence T. Rimsky;Diane C. Shugars;Thomas J. Matthews.
Journal of Virology (1998)
Changing Bee and Hoverfly Pollinator Assemblages along an Urban-Rural Gradient
Adam J. Bates;Jon P. Sadler;Alison J. Fairbrass;Steven J. Falk.
PLOS ONE (2011)
Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.
John J. Dwyer;Karen L. Wilson;Donna K. Davison;Stephanie A. Freel.
Proceedings of the National Academy of Sciences of the United States of America (2007)
Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults
Mary Lou Clements-Mann;Kent Weinhold;Thomas J. Matthews;Barney S. Graham.
The Journal of Infectious Diseases (1998)
Island biogeography: Taking the long view of nature’s laboratories
Augmentation of Human Immunodeficiency Virus Type 1 Neutralizing Antibody by Priming with gp160 Recombinant Vaccinia and Boosting with gp160 in Vaccinia-Naive Adults
Barney S. Graham;Thomas J. Matthews;Robert B. Belshe;Mary Lou Clements.
The Journal of Infectious Diseases (1993)
Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates.
Prakash R Sista;Tom Melby;Donna Davison;Lei Jin.
A Prime-Boost Approach to HIV Preventive Vaccine Using a Recombinant Canarypox Virus Expressing Glycoprotein 160 (MN) followed by a Recombinant Glycoprotein 160 (MN/LAI)
Gilles Pialoux;Jean-Louis Excler;Yves Rivière;Gustavo Gonzalez-Canali.
AIDS Research and Human Retroviruses (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: